Bristol Myers Squibb Co (BMY)

Aug 26, 2025

Order flow analysis tools used on Bristol Myers Squibb Company Equity RightMarket Movement Recap & Step-by-Step Trade Execution Guides - Newser

Aug 26, 2025

Aug 26, 2025

Signal strength of Bristol Myers Squibb Company stock in tech scannersJuly 2025 Highlights & Free Risk Controlled Daily Trade Plans - Newser

Aug 26, 2025

Aug 26, 2025

Analyzing Bristol Myers Squibb Company with multi timeframe chartsPortfolio Performance Report & Daily Volume Surge Trade Alerts - Newser

Aug 26, 2025

Aug 26, 2025

Is Bristol Myers Squibb Company stock bottoming outWeekly Stock Analysis & Safe Capital Investment Plans - Newser

Aug 26, 2025

Aug 26, 2025

Can Bristol Myers Squibb Company hit a new high this monthMarket Movement Recap & Daily Oversold Stock Bounce Ideas - Newser

Aug 26, 2025

Aug 26, 2025

Scenic Enters License and Research Agreement with Alnylam - GlobeNewswire Inc.

Aug 26, 2025

Aug 25, 2025

Bristol Myers Squibb Co. stock underperforms Monday when compared to competitors - MarketWatch

Aug 25, 2025

Aug 25, 2025

Business development leadership team - Bristol Myers Squibb

Aug 25, 2025

Aug 22, 2025

BMY vs GSK: Which Biopharma Bigwig Has Better Prospects for Now? - Yahoo Finance

Aug 22, 2025

Aug 22, 2025

Career oncologist makes Big Pharma leap to BMS—Chutes & Ladders - Fierce Biotech

Aug 22, 2025

Aug 22, 2025

ServiceNow, Live Nation Entertainment And A Health Care Stock: CNBC's 'Final Trades' - Benzinga

Aug 22, 2025

Aug 22, 2025

Lilly neuro exec Anne White to retire; Bristol Myers fills new medical affairs position - Endpoints News

Aug 22, 2025

Aug 21, 2025

Is Bristol Myers Squibb Company impacted by rising ratesPortfolio Update Report & Community Driven Trade Alerts - theviewers.co.kr

Aug 21, 2025

Aug 20, 2025

Agilent, Bristol Myers win FDA nod for cancer test (A:NYSE) - Seeking Alpha

Aug 20, 2025

Aug 19, 2025

Bristol Myers Squibb Stock Surges on FDA Breakthrough Designation for Lung Cancer Drug Despite Ranking 217th in Trading Volume - AInvest

Aug 19, 2025

Aug 19, 2025

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields - Benzinga

Aug 19, 2025

Aug 19, 2025

Bristol Myers Squibb, SystImmune gets USFDA Breakthrough Therapy Designation for izalontamab brengitecan... - Medical Dialogues

Aug 19, 2025

Aug 19, 2025

Bristol Myers Squibb's Lung Cancer Drug Secures FDA Breakthrough Status - AInvest

Aug 19, 2025

Aug 19, 2025

Bristol Myers Squibb Company stock outlook for YEAR2025 Volume Leaders & AI Driven Stock Movement Reports - Newser

Aug 19, 2025

Aug 18, 2025

Israel issues first antitrust fine to a global pharmaceutical company - Global Competition Review

Aug 18, 2025

Aug 18, 2025

FESTIVAL ANNOUNCEMENT: 31st One Mind Music Festival (Feat. Train) Presented by Bank of America and Bristol Myers Squibb - Enidnews.com

Aug 18, 2025

Aug 18, 2025

Bristol Myers and SystImmune’s lung cancer drug gets FDA boost - Investing.com

Aug 18, 2025

Aug 18, 2025

The Zacks Analyst Blog Highlights Lowe's, Bristol-Myers Squibb, Marvell Technology and Kewaunee Scientific - Yahoo Finance

Aug 18, 2025

Aug 18, 2025

Izalontamab Brengitecan (EGFRxHER3 ADC) Granted Breakthrough Therapy Designation by U.S. FDA for Patients with Previously Treated Advanced EGFR-Mutated Non-Small Cell Lung Cancer – Company AnnouncementFT.com - Financial Times

Aug 18, 2025

Aug 17, 2025

Bristol Myers (BMY) Partners with Bain Capital to Create Immunology Therapies - uk.finance.yahoo.com

Aug 17, 2025

Aug 16, 2025

Greenlight Capital Announces Q2 2025 Trades: New Positions in FLR and VSCO, Exit From VTRS - Benzinga

Aug 16, 2025

Aug 15, 2025

Lowe's, Bristol-Myers, and Marvell Technology: Key Research Reports - AInvest

Aug 15, 2025

Aug 15, 2025

Top Research Reports for Lowe's, Bristol-Myers & Marvell Technology - Yahoo Finance

Aug 15, 2025

Aug 15, 2025

Bristol-Myers Squibb’s Promising Phase 3 Alzheimer’s Study: Market Implications - TipRanks

Aug 15, 2025

Aug 15, 2025

Bristol-Myers Squibb’s New Study on NSCLC Treatment: Market Implications - TipRanks

Aug 15, 2025

Aug 15, 2025

Layoff Tracker: Bausch Health Closes California Site, Cuts 49 Employees - BioSpace

Aug 15, 2025

Aug 14, 2025

Bristol-Myers Squibb’s Promising Phase 3 Study on Deucravacitinib for Sjögren’s Syndrome - TipRanks

Aug 14, 2025

Aug 14, 2025

Bristol-Myers Squibb and Incyte’s Cancer Study Update: Market Implications - TipRanks

Aug 14, 2025

Aug 14, 2025

Pfizer and Bristol-Myers Squibb’s Promising Study on Multiple Myeloma Treatment - TipRanks

Aug 14, 2025

Aug 14, 2025

Bristol-Myers Squibb’s New Psoriasis Study: A Long-Term Safety Evaluation - TipRanks

Aug 14, 2025

Aug 14, 2025

Anal Cancer Market Is Going to Boom | Major Giants Merck & Co., Roche, Bristol-Myers Squibb, Pfizer - newstrail.com

Aug 14, 2025

Aug 13, 2025

Bristol-Myers Squibb stock price target lowered to $45 at Cantor Fitzgerald - Investing.com Nigeria

Aug 13, 2025

Aug 12, 2025

Testicular Cancer Market Analysis and Forecast Report 2025-2035 | Competitive Analysis of Bristol Myers Squibb, Pfizer, Eli Lilly, Merck, Novartis, Amgen, F. Hoffmann-La RocheResearchAndMarkets.com - Bluefield Daily Telegraph

Aug 12, 2025

Aug 12, 2025

Multiple Myeloma Market Trends and Company Analysis Report 2025-2033 Featuring BMS, Novartis, Abbvie, Sanofi, Johnson and Johnson, Baxter, Pfizer, and Takeda - uk.finance.yahoo.com

Aug 12, 2025

Aug 12, 2025

Can Bristol Myers Squibb Company lead its sector in growthHigh Yield Growth Opportunities - mustnews.co.kr

Aug 12, 2025

Aug 11, 2025

Hung Trinh: BioNTech SE and Bristol Myers Squibb Partner on Next-Gen Bispecific Antibody for Solid Tumors - Oncodaily

Aug 11, 2025

Aug 10, 2025

Yan Leyfman: FDA Accepts Bristol Myers Squibb's Breyanzi for Priority Review as a Potential Treatment for Relapsed MZL - Oncodaily

Aug 10, 2025

Aug 09, 2025

Jim Cramer on Bristol-Myers: “Have Not Been Recommending the Stock” - Insider Monkey

Aug 09, 2025

Aug 08, 2025

Bristol-Myers Squibb Stock: Is BMY Outperforming the Healthcare Sector? - MSN

Aug 08, 2025

Aug 08, 2025

Bristol Myers Squibb Named Top Dividend Stock With Insider Buying and 5.47% Yield (BMY) - Nasdaq

Aug 08, 2025

Aug 08, 2025

Bristol-Myers Squibb’s Promising Phase 3 Study on BMS-986278: A Potential Game-Changer for Pulmonary Fibrosis - TipRanks

Aug 08, 2025

Aug 08, 2025

Bristol Myers Squibb (NYSE:BMY) Cut to Neutral at Daiwa Capital Markets - Defense World

Aug 08, 2025

Aug 07, 2025

Car T Cell Therapy For Multiple Myeloma Market Growth to Accelerate in Forecast Period (2024-2032), DelveInsight Analyzes by DelveInsight | Johnson & Johnson, Gadeta, Bristol-Myers Squibb, Bluebird - Barchart.com

Aug 07, 2025

Aug 06, 2025

Stock Analysis | Bristol-Myers Squibb OutlookNavigating Weak Technicals Amid Mixed Fundamentals - AInvest

Aug 06, 2025

Aug 06, 2025

FDA Accepts Breyanzi sBLA from Bristol Myers Squibb and Grants It Priority Review for MZL - BioPharm International

Aug 06, 2025

Aug 06, 2025

Bristol Myers Squibb Q1 2025 slides: portfolio transformation gains momentum as guidance raised - Investing.com Nigeria

Aug 06, 2025

Aug 06, 2025

Bristol Myers Squibb Q1 2025 slides: portfolio transformation gains momentum as guidance raised By Investing.com - Investing.com South Africa

Aug 06, 2025

Aug 05, 2025

Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Aug 05, 2025

Aug 05, 2025

3 Dividend Stocks for August 2025 - Morningstar

Aug 05, 2025

Aug 05, 2025

Bristol Myers Beats on Q2 Earnings and Sales, Raises '25 Sales View - MSN

Aug 05, 2025

Aug 04, 2025

Bristol Myers Squibb: Why I'm Pounding The Table On This Buying Opportunity (NYSE:BMY) - Seeking Alpha

Aug 04, 2025